Estatísticas para OP0147 THE SLE-DAS REMISSION AND LOW DISEASE ACTIVITY STATES DISCRIMINATE DRUG FROM PLACEBO AND BETTER HEALTH-RELATED QUALITY OF LIFE: POST-HOC ANALYSIS OF THE BLISS-52 AND BLISS-76 PHASE III TRIALS.
Total de visitas
| views | |
|---|---|
| OP0147 THE SLE-DAS REMISSION AND LOW DISEASE ACTIVITY STATES DISCRIMINATE DRUG FROM PLACEBO AND BETTER HEALTH-RELATED QUALITY OF LIFE: POST-HOC ANALYSIS OF THE BLISS-52 AND BLISS-76 PHASE III TRIALS. | 52 |
Total de visitas por mês
| views | |
|---|---|
| agosto 2025 | 0 |
| setembro 2025 | 0 |
| outubro 2025 | 0 |
| novembro 2025 | 0 |
| dezembro 2025 | 2 |
| janeiro 2026 | 0 |
| fevereiro 2026 | 0 |
Downloads
| views | |
|---|---|
| 2022_EULAR-OP0147-SLE-DAS_remission_and_low_disease_activity_states_are_associated_with_improved_health-related.pdf | 31 |
Top de consultas por país
| views | |
|---|---|
| Estados Unidos | 14 |
| Portugal | 8 |
| China | 6 |
| Índia | 4 |
| Austrália | 3 |
| Canadá | 3 |
| Reino Unido | 2 |
| Japão | 2 |
| Ucrânia | 2 |
| Bulgária | 1 |
| Brasil | 1 |
| Alemanha | 1 |
| Letónia | 1 |
| Singapura | 1 |
| Taiwan | 1 |